Improving long-term outcomes for transplant patients: Making the case for long-term disease-specific and multidisciplinary research

American Journal of Transplantation

Volumn 11, Issue 10, 2011, Pages 2264-2265

  Lodhi, S A ^a   Lamb, K E ^b   Meier Kriesche, H U ^c  

^a EMORY UNIVERSITY   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; LETTER; MEDICARE; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RACE DIFFERENCE; RISK FACTOR; SOCIOECONOMICS; TRANSPLANTATION;

GRAFT SURVIVAL; HUMANS; ORGAN TRANSPLANTATION;

EID: 80053338777     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03713.x     Document Type: Letter

References (6)

1. De Geest S, Dobbels F, Gordon E, De Simone P,. Chronic illness management as an innovative pathway for enhancing long-term survival in transplantation. Am J Transplant 2011; 11: 2262-2263.
2. Tinetti ME, Studenski SA,. Comparative effectiveness research and patients with multiple chronic conditions. N Engl J Med 2011; Epub ahead of print.
3. Kullgren JT, Galbraith AA, Hinrichsen VL, et al,. Health care use and decision making among lower-income families in high-deductible health plans. Arch Intern Med 2010; 170: 1918-1925.
4. Gordon EJ, Prohaska TR, Sehgal AR,. The financial impact of immunosuppressant expenses on new kidney transplant recipients. Clin Transplant 2008; 22: 738-748.
5. Lamb KE, Lodhi S, Meier-Kriesche HU,. Long-term renal allograft survival in the United States: A critical reappraisal. Am J Transplant 2011; 11: 450-462.
6. Srinivas TR, Meier-Kriesche HU,. Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result. Clin J Am Soc Nephrol 2008; 3 (Suppl 2): S101-S116.